The BioTech Breakouts Strategy – 3 Simple Steps:
Kyle Dennis is a 26 year old multi-millionaire trader who runs his own stock trading educational service, BioTech Breakouts. His service focuses solely on stocks within the biotechnology sector, which can provide massive opportunities for profit on catalyst run-ups. This type of focused approach allows his members to learn the strategy inside-and-out, and apply it on a relatively narrow group of stocks on a daily basis. Overall, his strategy is extremely simple for anyone to understand, and best of all – it’s effective.
#1: Find a Catalyst
This is arguably the most important aspect of Kyle’s strategy. A catalyst is a reason a stock might move in one direction or the other. When it comes to the biotechnology sector, these catalysts typically come in the form of Phase 1/2/3 data releases, PDUFA’s, AdCom meetings, presentations at conferences, etc. Leading up to such events, speculation and hype can build around the drugs being produced by various companies, resulting in an uptrend in share price as the particular event approaches. The best catalysts are ones with set dates, meaning they are scheduled to take place on a specific day (not month or quarter).
[Best Resource: BioPharmCatalyst.com]
#2: Pair it With a Good Chart
Once a quality catalyst has been found, it’s time to perform some technical and fundamental research on that particular ticker. You can check recent news, view analyst reports, analyze insider activity, etc. If all that checks out, a candlestick chart can be used to evaluate potential entry and exit points. Within this same step, risk vs. reward can be calculated. Using simple support and resistance concepts, you can decide on potential areas to buy and sell. The more criteria that adds up, the better: good catalyst, solid financials, insider buying, bullish chart pattern, etc. It’s at this stage where a detailed trade plan can be created and then put into action.
[Best Resource: Finviz.com]
#3: Don’t Hold Through Events
The catalyst events that Kyle and his members are trading around provide a specific timeframe for which the trade can pan out. But holding through the event itself can be extremely risky. If data is good, stocks can potentially double in value, but on the flip-side if data is bad, stock value can potentially be cut in half. Holding through the catalyst itself isn’t part of Kyle’s strategy. His approach is to take advantage of the speculation leading up to such events, with the idea that a run-up will occur. Holding through events is essentially a 50-50 gamble – not the odds Kyle Dennis and his members are looking for.
[Best Resource: BioTechBreakouts.com]
Conclusion – Does the Catalyst-Driven Strategy at BioTech Breakouts Work?
Over the course of the past few years, Kyle Dennis has captured over $2,000,000 in profits utilizing the strategy outlined above – clear proof that it works. Of course there’s more concepts that he covers within his newsletter, but this is a broad explanation of how he has made millions in the markets. Overall, it’s not all that difficult to understand, but most individuals aren’t motivated enough to actually learn how to implement this strategy on their own. They’re merely focused on “hot picks” or blindly copying others.
|How to Turn $15,000 Into Over $1,000,000 Trading Stocks in Less Than 3 Years|
|An Inside Look at How Kyle Dennis Finds Catalysts and Consistently Profits From Them|
Bottom Line: Kyle Dennis is one of the best teachers on Wall Street. He might even be a better teacher than trader – and that’s saying a lot. His supreme focus is on education and making his members self-sufficient. He openly shares every aspect of his strategy and creates video lessons to share with his members on a consistent basis. It’s no surprise that his educational service has quickly become one of the best available on Wall Street.
Written by Matt Thomas
Related Pages:
- BioTech Breakouts Review – Kyle Dennis Turned $15K Into Over $1M
- An Inside Look at How Kyle Dennis Turned $15K Into Nearly $2M
- Interview With Kyle Dennis – Jason Bond’s First Verified Millionaire Student
- 3 Ways to Follow and Learn From Kyle Dennis (Millionaire Trader) For Free
- Millionaire Jason Bond Picks Client, Kyle Dennis, Launches Own Newsletter
Hello Matt. I used to be interested in binary option trading, but I realized it wasn’t for me and I came across online business to pursue instead. I can honestly say that trading isn’t for everyone, but for the people that are into trading stocks, I recommend that they read about Kyle Dennis and his approach. Based on Kyle’s success, members should be successful too if they follow his 3-pronged strategy to trading biotech stocks. Sounds like it would work with much more consistency than binary options.
He’s 26 and a millionaire? He has my respect. I’m curious how much of his knowledge have you been able to profit from. Has he made you any money?
I know nothing about biotech or the biotech industry. To be honest, the terms intimidate me. Having said that, I wouldn’t know a catalyst in the biotech realm if it stared me in the face.
I’m not being cynical. I’m being honest. At this point, I’m not sure I’m even interested in learning about it. The steps you’ve provided are simple enough but the subject matter is more advanced than I’m up to at this time. Perhaps I’m in my own way.
I wish you and all who delve into it all the best.
Hi Bob – that’s correct. Kyle Dennis just recently turned 27 and he’s a multi-millionaire stock trader. He’s best known for taking $15,000 and turning it into $1,000,000 as a member of Millionaire Roadmap, but he’s well past the $3,000,000 profit mark at this time. Just about two months ago, he decided to drop his typical trading portfolio down to $25,000 with the goal of turning it into $1,000,000 yet again. So far, That Portfolio is up Over 200% in what Kyle has dubbed the Million Dollar Mission.
Before learning about Kyle Dennis, I didn’t know much at all about the biotech industry either. But he has a defined strategy that works on a consistent basis, and best of all, he teaches it to his students with patience and discipline. He teaches exactly how to scan for ideal technical setups using Finviz, search for catalysts in the sector using BioPharmCatalyst, and every other aspect of his “bread and butter” strategy. He’s always an open book when it comes to answering questions, in addition to Live Streaming His Trading Screen during market hours for his Nucleus members. There’s absolutely no better way to learn how to trade than watch a successful trader’s every move day-in and day-out.
It can certainly be intimidating trying something new, but the services that Kyle Dennis has to offer can provide expert guidance for even the least experienced traders. That’s mainly because the focus is primarily on education. Producing a community of traders that have a clear understanding of concepts, can pinpoint opportunities in the markets, and execute on them completely on their own. It’s not about blindly mirror alerts. A lot of the time that’s what people think they want – alerts. But blindly mirroring anyone’s buys & sells is a dangerous game without the proper education and risk management.
Kyle’s Biotech Catalyst Swing Trading strategy is one of my favorites and I’ve certainly made some nice profits using it. Check out some examples of trades I’ve made in this Biotech Breakouts Review. Unfortunately, I don’t have a breakdown of all of the biotech catalyst swing trades I’ve made thus far (and haven’t made many lately with my focus on a couple other services currently under review), but Kyle’s own success and hundreds of client testimonials can do most of the talking. Take care!
This is a good read. Im recently reading more and more about stocks and this is a well informed write up and has filled in a lot of blanks for me. As others have said though, I was also in the opinion that biotech stocks and pharmaceuticals are a volatile area generally so im curious about Kyle’s input here too.
Hi Chris. Biotech and pharmaceutical stocks certainly tend to be volatile, but that’s not necessarily a bad thing. What Kyle puts into practice, and teaches his students to do as well, is to take advantage of that volatility to the upside while reducing the risk to the downside.
For example, his main strategy involves capturing profits on run-ups into various FDA events and data readouts. He reduces risk by never holding through the event itself (that’s merely a gamble), but takes advantage of the excitement and hype leading up to it. He also performs fundamental and technical analysis in order to understand company history, past performance, how executives are compensated, institutional interest, average daily volume, and more. He puts the odds and volatility (increased profit-potential) in his favor with research and discipline.
If you want to get in contact directly with Kyle Dennis in order to ask him questions, he’s active on Twitter and his Blog. He’s open to answering all questions regarding his trading strategies. Take care!
Matt,
The biotech industry seems inherently volatile. Wouldn’t you agree this is similar to pharmaceutical companies? While reading this, I couldn’t help but think about earnings play strategies. Would Kyle’s training talk about options strategies like a strangle to use during these volatile catalysts or is this strictly stock trading? Thanks
Hi Neil. Biotech is certainly similar to pharmaceutical companies – those terms are pretty much synonymous. As far as catalysts go, Kyle’s main strategy includes run-ups into phase 1,2, or 3 data readouts and not so much earnings plays. Within his Biotech Nucleus program, he certainly trades and alerts options plays in addition to stock trades, but I’m unsure if he uses a strangle strategy. In all honesty, I’ve never heard of that term (I mainly stick to stock trading), but feel free to reach out directly to Kyle to ask. Contact Kyle Dennis.
Matt,
It’s refreshing to have someone in the financial industry be honest like this. It’s a good sign when someone shows vulnerability like that. So many people feel the need to be the expert that has all the answers all of the time. Kudos to you and thank you for the quick and honest reply!
I have always been fascinated with stock trading. Just don’t know how to begin. But you have shown me where to start. I understand the Twitter account, But where do I find Seeking Alpha? & BioTech Breakouts? are they from a website or facebook? Id like to track the information before I make any decisions.
Thanks Brian.
Hi Brian. It seems like you’re referring to this article: 3 Ways to Follow and Learn From Kyle Dennis For Free. The Twitter, Seeking Alpha, and BioTech Breakouts links are all available there.
Seeking Alpha is a website full of financial articles and research – Kyle Dennis is a frequent contributor of biotech reports on that platform. BioTech Breakouts is his personal website, which offers a free email list that anybody can sign up for, as well as a blog containing video lessons, webinars, portfolio summaries, and various other educational content. Hope that helps – Take care!